Works matching DE "VACCINE approval"

Results: 275
    1

    A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 797, p. 1, doi. 10.1126/scitranslmed.adn1441
    By:
    • Dold, Christina;
    • Oguti, Blanché;
    • Silva-Reyes, Laura;
    • Stanzelova, Anna;
    • Raymond, Meriel;
    • Smith, Catherine C.;
    • Moore, Maria;
    • Barton, Anna;
    • Choi, Edward M.;
    • Plested, Emma;
    • Tanha, Kiarash;
    • Louth, Jennifer;
    • Holland, Ann;
    • Cook, Robert;
    • King, Jessica;
    • Lucidarme, Jay;
    • Borrow, Ray;
    • Hill, Adrian V. S.;
    • Beernink, Peter T.;
    • Liu, Xinxue
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Filistin 2021.

    Published in:
    Middle East Yearbook / Ortadoğu Yıllığı, 2021, p. 75
    By:
    • Toçoğlu, Fatma Zehra
    Publication type:
    Article
    8
    9
    10
    11

    An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).

    Published in:
    PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0287416
    By:
    • Moin, Abu Tayab;
    • Rani, Nurul Amin;
    • Ullah, Md. Asad;
    • Patil, Rajesh B.;
    • Robin, Tanjin Barketullah;
    • Nawal, Nafisa;
    • Zubair, Talha;
    • Mahamud, Syed Iftakhar;
    • Sakib, Mohammad Najmul;
    • Islam, Nafisa Nawal;
    • Khaleque, Md. Abdul;
    • Absar, Nurul;
    • Shohael, Abdullah Mohammad
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Botulinum Neurotoxins as Two-Faced Janus Proteins.

    Published in:
    Biomedicines, 2025, v. 13, n. 2, p. 411, doi. 10.3390/biomedicines13020411
    By:
    • Chimienti, Silvia;
    • Di Spirito, Maria;
    • Molinari, Filippo;
    • Rozov, Orr;
    • Lista, Florigio;
    • D'Amelio, Raffaele;
    • Salemi, Simonetta;
    • Fillo, Silvia
    Publication type:
    Article
    18
    19

    Silent risk: the vertical transmission of Oropouche virus.

    Published in:
    European Journal of Clinical Microbiology & Infectious Diseases, 2025, v. 44, n. 1, p. 209, doi. 10.1007/s10096-024-04975-9
    By:
    • Garima S, Kukreja;
    • Priyanka S, Khopkar-Kale;
    • Srikanth P, Tripathy;
    • Jitendra S, Bhawalkar
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Targeted Immunization Strategies and Designing Vaccine against Indian Nipah Virus Strain (NiV B) and Malaysian Variant (NiV M).

    Published in:
    International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 4, p. 1201, doi. 10.5530/ijpi.14.4.131
    By:
    • Pariyapurath, Naseera Kannanthodi;
    • Jagannathan, Selvaraj;
    • Mathanmohun, Maghimaa;
    • Pillai, Sarika Baburajan;
    • Dhandapani, Kavitha;
    • Pachamuthu, Rahul Gandhi;
    • Channappa, Shivanandappa Kukkaler;
    • Sakthivel, Sivakumar;
    • Namassivayam, Hemapriya
    Publication type:
    Article
    31

    Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 741, p. 1, doi. 10.1126/scitranslmed.adl2055
    By:
    • Zeitlin, Larry;
    • Cross, Robert W.;
    • Woolsey, Courtney;
    • West, Brandyn R.;
    • Borisevich, Viktoriya;
    • Agans, Krystle N.;
    • Prasad, Abhishek N.;
    • Deer, Daniel J.;
    • Stuart, Lauren;
    • McCavitt-Malvido, Maria;
    • Kim, Do H.;
    • Pettitt, James;
    • Crowe Jr., James E.;
    • Whaley, Kevin J.;
    • Veesler, David;
    • Dimitrov, Antony;
    • Abelson, Dafna M.;
    • Geisbert, Thomas W.;
    • Broder, Christopher C.
    Publication type:
    Article
    32
    33

    COVID-19 and neurology perspective.

    Published in:
    Hormone Molecular Biology & Clinical Investigation, 2021, v. 42, n. 1, p. 69, doi. 10.1515/hmbci-2020-0069
    By:
    • Singh, Shivani;
    • Ahirwar, Ashok Kumar;
    • Asia, Priyanka;
    • Gopal, Niranjan;
    • Kaim, Kirti;
    • Ahirwar, Pradeep
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51046-w
    By:
    • Gagne, Matthew;
    • Flynn, Barbara J.;
    • Honeycutt, Christopher Cole;
    • Flebbe, Dillon R.;
    • Andrew, Shayne F.;
    • Provost, Samantha J.;
    • McCormick, Lauren;
    • Van Ry, Alex;
    • McCarthy, Elizabeth;
    • Todd, John-Paul M.;
    • Bao, Saran;
    • Teng, I-Ting;
    • Marciano, Shir;
    • Rudich, Yinon;
    • Li, Chunlin;
    • Jain, Shilpi;
    • Wali, Bushra;
    • Pessaint, Laurent;
    • Dodson, Alan;
    • Cook, Anthony
    Publication type:
    Article
    48
    49
    50